Parallel Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3694 |
|
|
2024
Q4 | – | Hold |
0
| – | -$1 | – | 3617 |
|
|
2024
Q3 | – | Hold |
0
| – | -$1 | – | 3379 |
|
|
2024
Q2 | – | Hold |
0
| – | -$4 | – | 3298 |
|
|
2024
Q1 | – | Hold |
0
| – | -$3 | – | 3261 |
|
|
2023
Q4 | – | Hold |
0
| – | -$7 | – | 3287 |
|
|
2023
Q3 | – | Sell |
-2
| Closed | -$252 | – | 3328 |
|
|
2023
Q2 | $252 | Buy |
+2
| New | +$252 | ﹤0.01% | 3213 |
|
|
2023
Q1 | – | Hold |
0
| – | -$43 | – | 3373 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3292 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3554 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3408 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3325 |
|
|
2021
Q4 | – | Sell |
-1
| Closed | -$1K | – | 3337 |
|
|
2021
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 2967 |
|
|
2021
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 2840 |
|
|
2021
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 2704 |
|
|
2020
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 2488 |
|
|
2020
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 2493 |
|
|
2020
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2761 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2697 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2516 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2514 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2453 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2421 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2334 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2319 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 2231 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | -$1K | – | 2240 |
|
|
2017
Q1 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 1933 |
|